News

Demonstrating Excellence in Outcomes and Culture

Onco360 Selected as a Limited Distribution Specialty Pharmacy Partner for Rytelo™ (imetelstat)

Home / News / Specialty Pharmacy / Page 3

Specialty Pharmacy | News

Stay up to date with the latest innovations, company updates, and industry insights as we work to advance health and wellness for all.

Onco360 - Rytelo

Onco360 Selected as a Limited Distribution Specialty Pharmacy Partner for Rytelo™ (imetelstat)

Onco360 Chief Commercial Officer Named 40 Under 40 in Cancer

OJEMDA™ (tovorafenib) Now Available from Onco360 for the Treatment of Patients Six Months of Age and Older with Relapsed or Refractory Pediatric Low-Grade Glioma (LGG) Harboring a BRAF Fusion or Rearrangement, or BRAF V600 Mutation

Onco360 Has Been Selected as the Sole National Specialty Pharmacy Partner for Voydeya® (danicopan)

Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor)

Fabhalta (iptacopan) Now Available from Onco360 as the First FDA-Approved Oral Monotherapy Approved for the Treatment of Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

WHAT PEOPLE ARE SAYING